Accentuating CircRNA-miRNA-Transcription Factors Axis: A Conundrum in Cancer Research

Deepti Singh1, Prashant Kesharwani2, Nabil A Alhakamy3

  • 1Molecular Cancer Genetics and Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh, India.

Frontiers in Pharmacology
|January 28, 2022
PubMed

Insights

Circular RNAs (circRNAs), stable non-coding RNAs, regulate gene expression and are implicated in cancer. The circRNA-miRNA-transcription factor (TF) axis influences cancer progression, offering therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Biology

Background:

  • Circular RNAs (circRNAs) are novel non-coding RNAs formed by back-splicing.
  • Initially dismissed as 'splicing noise,' circRNAs are now recognized for diverse biological functions.
  • Emerging evidence highlights their dysregulation and oncogenic roles in various cancers.

Purpose of the Study:

  • To review the biogenesis, localization, and functions of circRNAs in cancer.
  • To elucidate the regulatory role of the circRNA-miRNA-transcription factor (TF) axis in cancer.
  • To discuss targeting this axis as a potential cancer therapeutic strategy.

Main Methods:

  • Literature review of circRNA research in cancer.
  • Analysis of circRNA functions including miRNA sponging and protein scaffolding.
  • Examination of the circRNA-miRNA-TF regulatory network in oncogenesis.

Main Results:

  • CircRNAs act as miRNA sponges, protein decoys, and regulators of transcription/translation.
  • The circRNA-miRNA-TF axis is crucial for cancer cell proliferation, invasion, and metastasis.
  • Differential expression of circRNAs is observed in multiple cancer types.

Conclusions:

  • CircRNAs are key players in cancer development and progression.
  • The circRNA-miRNA-TF axis represents a significant regulatory network in oncology.
  • Targeting circRNAs and their associated pathways offers a promising avenue for cancer therapy.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
78.8K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.1K